The Thoracic Society of Australia and New Zealand has updated its guidelines on corticosteroid use in childhood asthma
The understanding of childhood asthma has increased substantially since the publication of the Thoracic Society of Australia and New Zealand (TSANZ) position statement The role of corticosteroids in the management of childhood asthma in 2002.1 In particular, recognition of the need for separate asthma management guidelines for children aged 5 years or younger has increased,2 and considerably more clinical research evidence on the role of asthma medications in children has become available. The 2010 revision of the TSANZ position statement provides updated recommendations on the roles of inhaled corticosteroids, oral corticosteroids, leukotriene receptor antagonists and combination medications (inhaled corticosteroids plus long-acting β-agonists) in childhood asthma management based on recently published evidence.3 The role of leukotriene receptor antagonists in the management of childhood asthma has also been addressed in detail in a recent National Asthma Council Australia information paper.4
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Van Asperen PP, Mellis CM, Sly PD, for the Thoracic Society of Australia and New Zealand . The role of corticosteroids in the management of childhood asthma. Med J Aust 2002; 176: 168-173. <MJA full text>
- 2. Global Initiative for Asthma. Global Strategy for the diagnosis and management of asthma in children 5 years and younger. 2009. http://www.ginasthma.com/Guidelineitem.asp??l1=2&l2=1&intId=1689 (accessed Mar 2011).
- 3. Van Asperen PP, Mellis CM, Sly PD, Robertson C, for the Thoracic Society of Australia and New Zealand. The role of corticosteroids in the management of childhood asthma. 2010. http://www.thoracic.org.au/imagesDB/wysiwyg/Steroidsinasthma_2010.pdf (accessed Mar 2011).
- 4. National Asthma Council Australia. Leukotriene receptor antagonists in the management of childhood asthma. Melbourne: NAC, 2010. http://www.nationalasthma.org.au/content/view/219/146 (accessed Mar 2011).
- 5. National Asthma Council Australia. Asthma management handbook 2006. Melbourne: NAC, 2006. http://www.nationalasthma.org.au/cms/index.php (accessed Mar 2011).
- 6. Chang AB, Landau LI, Van Asperen PP, et al. Cough in children: definitions and clinical evaluation. Position statement of the Thoracic Society of Australian and New Zealand. Med J Aust 2006; 184: 398-403. <MJA full text>
Peter Van Asperen, Craig Mellis and Colin Robertson are members of the MSD (Australia) Paediatric Respiratory Physician Advisory Board and have received speaker fees from MSD (Australia) for presentations on management of asthma and wheeze in children. They are also members the GlaxoSmithKline Paediatric Respiratory Taskforce, which was convened to ensure appropriate prescribing of Seretide in children. Craig Mellis has also received payment for reviewing topics and chapters of UpToDate (an electronic textbook).